Cynthia A. Sirard

Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic Leukemia

Peter Hillmen, Aleksander B. Skotnicki, Tadeusz Robak et al. · Journal of Clinical Oncology · 2007 · 555 citations · Full text

Rational design of anti-GITR-based combination immunotherapy

Roberta Zappasodi, Cynthia A. Sirard, Yanyun Li et al. · Nature Medicine · 2019 · 224 citations · Full text

Rational Design, Immunology, Biological Therapy +3

Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial

Thomas Elter, Liana Gercheva, Halyna Pylylpenko et al. · The Lancet Oncology · 2011 · 92 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +8

Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer

David R. Wise, Jeffrey A. Schneider, Joshua Armenia et al. · JCO Precision Oncology · 2020 · 59 citations · Full text

Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer

Lipika Goyal, Cynthia A. Sirard, Michael Schrag et al. · Clinical Cancer Research · 2020 · 54 citations · Full text